Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Industry Insights Seminar Series is hosted by the Business Partnerships Office

  • First Thursday of every month
  • 12.00 -1.00 pm 
  • In person and via Zoom
  • Networking & 1:1 meeting opportunities

Selected industry speakers provide seminars that are scientific in nature, across a range of medical or health topics.  Speakers are encouraged to bring along colleagues providing the opportunity for Oxford scientists to attend a scientific seminar of interest and also to network with industry scientists. One to one meetings can be facilitated upon request.  Seminars are suitable for all scientists with some knowledge or interest in each topic area, from PhD students to PIs.  Although mostly aimed at an academic audience, those located in the BioEscalator and Wood Centre, as well as local spinouts, are welcome to attend. 

Please contact Sheena Lee if you have any questions or have an industry partner you would like to invite to speak

2nd February 2023: Olink

Title: Understanding human disease in the post-genomics era

Presenters: Daniel Tomé, PhD, (Business Development Manager, UK) and Mariana Fontes PhD (Scientific Director - Neuroscience)

Company: Olink

Description: OLink is a high quality proteomics company, involved in the UK Biobank Pharma Proteomics Project, that resulted in an updated genetic atlas of the plasma proteome.   With the recent establishment of the Oxford-GSK Institute, Olink® Explore will be utilized to build a multiomics approach to mapping molecular mechanisms of complex diseases such as Parkinson’s and Alzheimer’s.   Expertise in machine learning and bioinformaticians at Oxford’s Big Data Institute will be able to leverage these datasets to pinpoint novel targets and identify signatures to stratify patients.

Register by clicking on the following link: Registration

2nd March 2023: Touchlight

Title: TBA

Presenters: TBA

Company: Touchlight

Description: Touchlight’s novel, synthetic DNA vector, “doggybone” or dbDNA™, and its enzymatic production, enable DNA to be made at the speed, scale and purity necessary to support the rapid growth of genetic medicines.

Register by clicking on the following link: Registration

On this page